Teva, Allergan Generics deal receives conditional EU clearance
MLex Summary: The European Commission has conditionally cleared plans by Teva Pharmaceutical Industries to acquire the generics business of Allergan. The EU watchdog was concerned that rivals wouldn’t be able to...To view the full article, register now.
Already a subscriber? Click here to view full article